Viewing Study NCT01205035


Ignite Creation Date: 2025-12-24 @ 10:03 PM
Ignite Modification Date: 2025-12-30 @ 5:50 PM
Study NCT ID: NCT01205035
Status: COMPLETED
Last Update Posted: 2015-04-10
First Post: 2010-09-16
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: High-Dose Lucentis (Ranibizumab 2.0mg) for the Treatment of Nonproliferative Idiopathic Parafoveal Telangiectasia
Sponsor: Eye Center of Northern Colorado, P.C.
Organization: